Cases 1 - 10 of 19
E. et al v. Regence Bluecross Blueshield of Utah et al
as 2:2022cv00700
Plaintiff:
R. E. and A. E.
Defendant:
Regence Bluecross Blueshield of Utah, Myriad Genetics Benefits Manager and Myriad Genetics CDHP Medical Plan
Cause Of Action: 29 U.S.C. § 1001 E.R.I.S.A.: Employee Retirement
H. et al v. Regence Bluecross Blueshield of Utah et al
as 2:2019cv01006
Defendant:
Myriad Genetics Inc. Health & Welfare Benefit Plan, the and Regence Bluecross Blueshield of Utah
Plaintiff:
C. H. and Larry H.
Cause Of Action: 29 U.S.C. § 1001
Silverman v. Myriad Genetics et al
as 2:2019cv00707
Defendant:
Myriad Genetics, R. Bryan Riggsbee and Mark C. Capone
Plaintiff:
Ethan Silverman
Kessman v. Myriad Genetics et al
as 2:2018cv00336
Plaintiff:
Matthew Kessman
Defendant:
Myriad Genetics, Mark Christopher Capone, Peter D. Meldrum and others
Cause Of Action: 15 U.S.C. § 0078
University of Utah Research Foundation et al v. Counsyl
as 2:2014cv00443
Plaintiff:
University of Utah Research Foundation , Trustees of the University of Pennsylvania , HSC Research and Development Limited Partnership and others
Defendant:
Counsyl
Cause Of Action: 35 U.S.C. § 0271
University of Utah Research Foundation et al v. Pathway Genomics
as 2:2014cv00442
Plaintiff:
University of Utah Research Foundation , Trustees of the University of Pennsylvania , HSC Research and Development Limited Partnership and others
Defendant:
Pathway Genomics
Cause Of Action: 35 U.S.C. § 0271
Invitae Corporation v. Myriad Genetics, Inc
as 2:2014cv00153
Plaintiff:
Invitae Corporation
Defendant:
Myriad Genetics
Cause Of Action: 15 U.S.C. § 1126
Quest Diagnostics Incorporated et al v. Myriad Genetics, Inc.
as 2:2014cv00152
Plaintiff:
Quest Diagnostics and Quest Diagnostics Nichols Institute
Defendant:
Myriad Genetics
Cause Of Action: 28 U.S.C. § 2201
Counsyl, Inc v. Myriad Genetics, Inc
as 2:2014cv00150
Plaintiff:
Counsyl, Inc
Defendant:
Myriad Genetics
Cause Of Action: 35 U.S.C. § 0145
In Re: BRCA1- and BRCA2- Based Hereditary Cancer Test Patent Litigation
as 2:2014md02510
Counter Defendant:
Invitae Corporation, Myriad Genetics, Quest Diagnostics and others
Counter Claimant:
Pathway Genomics and Ambry Genetics
Undetermined:
Labroratory Corporation of America Holdings, AARP, GeneDX and others
In Re:
BRCA1- and BRCA2- Based Hereditary Cancer Test Patent Litigation
Cause Of Action: 35 U.S.C. § 0271
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
